论文部分内容阅读
胃癌是全世界第二大癌症杀手。几十年来,胃癌被认为是一种具有化学抗性的肿瘤。本文旨在评价紫杉醇、优福定(替加氟,即口服5-氟尿嘧啶的前药及尿嘧啶以1∶4摩尔比的复方)以及亚油酸新复合疗法的应答率及安全性。2003年2月到2004年5月之间,来自6个医疗中心的55名患者被纳入此项
Gastric cancer is the second largest cancer killer in the world. For decades, gastric cancer is considered a chemically resistant tumor. This article aims to evaluate the response rate and safety of paclitaxel, youfudai (tegafur, a prodrug of oral 5-fluorouracil and uracil in a 1: 4 molar ratio), and linoleic acid neoadjuvant. Between February 2003 and May 2004, 55 patients from six medical centers were included